135 related articles for article (PubMed ID: 19627536)
1. Adrenomedullin, Bcl-2 and microvessel density in normal, hyperplastic and neoplastic endometrium.
Nunobiki O; Nakamura M; Taniguchi E; Utsunomiya H; Mori I; Tsubota Y; Mabuchi Y; Kakudo K
Pathol Int; 2009 Aug; 59(8):530-6. PubMed ID: 19627536
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
Vaskivuo TE; Stenbäck F; Tapanainen JS
Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
4. Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth.
Oehler MK; Norbury C; Hague S; Rees MC; Bicknell R
Oncogene; 2001 May; 20(23):2937-45. PubMed ID: 11420706
[TBL] [Abstract][Full Text] [Related]
5. Significance of hormone receptor status and tumor vessels in normal, hyperplastic and neoplastic endometrium.
Nunobiki O; Taniguchi E; Ishii A; Tang W; Utsunomiya H; Nakamura Y; Mori I; Kakudo K
Pathol Int; 2003 Dec; 53(12):846-52. PubMed ID: 14629750
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
[TBL] [Abstract][Full Text] [Related]
7. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
8. The role of immunohistochemical adrenomedullin and Bcl-2 expression in development of type-1 endometrial adenocarcinoma: Adrenomedullin expression in endometrium.
Bozkurt KK; Yalçın Y; Erdemoğlu E; Tatar B; Erdemoğlu E; Çerçi SS; Çiriş İM; Başpınar Ş; Uğuz A; Kapucuoğlu N
Pathol Res Pract; 2016 May; 212(5):450-5. PubMed ID: 26972419
[TBL] [Abstract][Full Text] [Related]
9. [Significance of proliferating cell nuclear antigen (PCNA) index and microvessel density (MVD) in endometrial carcinoma].
Xiao L; Tang LD
Ai Zheng; 2005 Jan; 24(1):19-22. PubMed ID: 15642194
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in normal, hyperplastic, and neoplastic endometrium.
Morgan KG; Wilkinson N; Buckley CH
J Pathol; 1996 Jul; 179(3):317-20. PubMed ID: 8774489
[TBL] [Abstract][Full Text] [Related]
11. Endometrial carcinoma associated with hyperplasia--immunohistochemical study of angiogenesis and p53 expression.
Kaku T; Kamura T; Hirakawa T; Sakai K; Amada S; Kobayashi H; Nakano H
Gynecol Oncol; 1999 Jan; 72(1):51-5. PubMed ID: 9889029
[TBL] [Abstract][Full Text] [Related]
12. [Expression of oncogene proteins Bag-1, p53, and bcl-2 in endometrium adenocarcinoma with different rate of differentiation].
Khadzhiolov N; Ivanov S
Akush Ginekol (Sofiia); 2004; 43 Suppl 2():35-6. PubMed ID: 15518275
[No Abstract] [Full Text] [Related]
13. Expression pattern of PAX2 in hyperplastic and malignant endometrium.
Kahraman K; Kiremitci S; Taskin S; Kankaya D; Sertcelik A; Ortac F
Arch Gynecol Obstet; 2012 Jul; 286(1):173-8. PubMed ID: 22274645
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis and Bcl-2 protein expression in patients with endometrial carcinoma.
Mazurek A; Pierzynski P; Niklinska W; Chyczewski L; Laudanski T
Neoplasma; 2002; 49(3):149-54. PubMed ID: 12097999
[TBL] [Abstract][Full Text] [Related]
15. BCL-2 and P53 expression in endometrial carcinoma.
Erkanli S; Eren F; Pekin S; Bagis T
J Exp Clin Cancer Res; 2004 Mar; 23(1):97-103. PubMed ID: 15149157
[TBL] [Abstract][Full Text] [Related]
16. Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis.
Oehler MK; Hague S; Rees MC; Bicknell R
Oncogene; 2002 Apr; 21(18):2815-21. PubMed ID: 11973640
[TBL] [Abstract][Full Text] [Related]
17. [Expression of receptor-binding cancer antigen expressed on SiSo cells in endometrial carcinoma and the correlation thereof with the expression of estrogen receptor subtypes].
Zhou XH; Xu ST; Song WY; Teng XD
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1900-3. PubMed ID: 17923013
[TBL] [Abstract][Full Text] [Related]
18. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172
[TBL] [Abstract][Full Text] [Related]
19. [A study of Bcl-2 expression in normal endometrium and endometrial carcinoma].
Zheng Y; Peng Z; Wang H
Hua Xi Yi Ke Da Xue Xue Bao; 1999 Mar; 30(1):92-5. PubMed ID: 12205937
[TBL] [Abstract][Full Text] [Related]
20. c-Kit proto-oncogene expression in endometrial hyperplasia and endometrial cancer.
Yilmaz E; Celik O; Simsek Y; Turkcuoglu I; Celik E; Gül M; Hascalik S; Aydin NE
Arch Gynecol Obstet; 2012 Jul; 286(1):197-200. PubMed ID: 22392489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
